DAA375 |
ubiquitin specific peptidase 6 (Tre-2 oncogene) |
USP6 |
5.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA1105 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
Increase DNA Methylation |
cerebellum |
Human |
|
DAA1108 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
Increase DNA Methylation |
temporal lobe |
Human |
|
DAA1106 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
Increase DNA Methylation |
frontal lobe |
Human |
|
DAA1107 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
B3GALT6 |
Increase DNA Methylation |
pons |
Human |
|
DAA2106 |
uridine-cytidine kinase 1-like 1 increases with age |
UCKL1 |
86.0% Increase Gene Expression Level |
ovary |
Human |
|
DAA384 |
vacuolar protein sorting 13 homolog C (S. cerevisiae) |
VPS13C |
3.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA2104 |
vacuolar protein sorting 13 homolog C (S. cerevisiae) decreases with age |
VPS13C |
58.7% Decrease Gene Expression Level |
ovary |
Human |
|
DAA423 |
vascular endothelial growth factor B |
VEGFB |
6.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA50 |
versican |
VCAN |
20.0% Increase Gene Expression Level |
brain |
Human |
|
DAA517 |
very low density lipoprotein receptor |
VLDLR |
4.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA245 |
vesicle-associated membrane protein 2 (synaptobrevin 2) |
VAMP2 |
4.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA246 |
vesicle-associated membrane protein 3 (cellubrevin) |
VAMP3 |
7.0% Increase Gene Expression Level |
brain |
Human |
|
DAA565 |
vesicle transport through interaction with t-SNAREs homolog 1B (yeast) |
VTI1B |
3.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA248 |
vimentin |
VIM |
11.0% Increase Gene Expression Level |
brain |
Human |
|
DAA249 |
visinin-like 1 |
VSNL1 |
6.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA247 |
voltage-dependent anion channel 1 |
VDAC1 |
10.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA2070 |
von Willebrand factor A domain containing 5A decreases with age |
VWA5A |
56.0% Decrease Gene Expression Level |
ovary |
Human |
|
DAA195 |
v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) |
RALB |
7.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA2078 |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) increases with age |
RELA |
60.0% Increase Gene Expression Level |
ovary |
Human |
|
DAA250 |
WD repeat and SOCS box-containing 2 |
WSB2 |
5.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA436 |
WD repeat domain 12 |
WDR12 |
3.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA2391 |
WNT1 inducible signaling pathway protein 2 precursor decreases with age |
WISP2 |
17.7% Decrease DNA Methylation |
dermis |
Human |
|
DAA2440 |
WNT1 inducible signaling pathway protein 2 precursor decreases with age |
WISP2 |
23.5% Decrease DNA Methylation |
mesenchymal stem cell |
Human |
|
DAA251 |
WW domain containing transcription regulator 1 |
WWTR1 |
24.0% Increase Gene Expression Level |
brain |
Human |
|